Kinney Horn
Corporate Officer/Principal chez IMMUNOME, INC.
Fortune : 27 825 $ au 31/03/2024
Profil
Mr. Kinney Horn is a Chief Business Officer at Immunome, Inc. Mr. Horn was previously employed as a Chief Business Officer by Olema Pharmaceuticals, Inc. and a Director-Business Development by Genentech, Inc. He received his undergraduate degree from the University of Mary Washington and a graduate degree from Georgetown University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/02/2023 | 2 458 ( 0,00% ) | 27 825 $ | 31/03/2024 |
Postes actifs de Kinney Horn
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOME, INC. | Corporate Officer/Principal | 01/02/2024 |
Anciens postes connus de Kinney Horn
| Sociétés | Poste | Fin |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 24/03/2023 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 01/04/2019 |
Formation de Kinney Horn
| Georgetown University | Graduate Degree |
| University of Mary Washington | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| OLEMA PHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
